Equities
  • Price (MXN)807.38
  • Today's Change-76.58 / -8.66%
  • Shares traded2.70k
  • 1 Year change--
  • Beta1.1365
Data delayed at least 20 minutes, as of Aug 16 2019 16:56 BST.
More ▼

Announcements

    Key statistics

    On Friday, Novozymes A/S (NZYMN:MEX) closed at 807.38, 0.00% above its 52-week low of 807.38, set on Aug 16, 2019.
    52-week range
    Today
    807.38Aug 16 20191,043.78Sep 25 2018
    Markit short selling activity
    Low
    Med
    High
    Open807.38
    High807.38
    Low807.38
    Bid--
    Offer--
    Previous close883.96
    Average volume2.30k
    Shares outstanding237.26m
    Free float159.48m
    P/E (TTM)24.86
    Market cap65.98bn DKK
    EPS (TTM)11.19
    DKK
    Annual div (ADY)14.69
    MXN
    Annual div yield (ADY)1.82%
    Div ex-dateFeb 28 2019
    Div pay-dateMar 04 2019
    Data delayed at least 20 minutes, as of Aug 16 2019 16:56 BST.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.